⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTMX News
CytomX Therapeutics, Inc.
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
GTBP
XNCR
CTMX
ZYME
NRIX
Form 8-K
sec.gov
CTMX
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
globenewswire.com
CTMX
REGN
CytomX Therapeutics to Present at Upcoming June Investor Conferences
globenewswire.com
CTMX
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
globenewswire.com
CTMX
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
globenewswire.com
CTMX
Form 8-K
sec.gov
CTMX
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
globenewswire.com
CTMX
Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company’s Scientific Advisory Board
globenewswire.com
CTMX
Form 8-K
sec.gov
CTMX